Resultado da Busca
5 de ago. de 2021 · The present joint European Association of Neuro-Oncology (EANO)–European Society for Medical Oncology (ESMO) recommendations for the diagnosis and treatment of parenchymal brain metastasis (BM) from solid cancers complement the first joint EANO–ESMO guideline on leptomeningeal metastasis from solid cancers.1 These recommendations address BMs from solid tumours, but do not address BMs from ...
28 de dez. de 2017 · INTRODUCTION. Colorectal cancer (CRC) is the third most common cancer, and the fourth leading cause of cancer-related deaths worldwide [1,2,3,4,5].With advances in the diagnostic radiographic techniques and treatment of CRC, survival of patients with CRC has improved over time and the incidence of brain metastasis (BM) from CRC has gradually increased as well [2,3,5,6,7,8,9].
1 de abr. de 2016 · Abbreviations: CRC Colorectal cancer, mCRC metastatic colorectal cancer, BM Brain metastases, WRBT Whole brain radiation therapy, SRS Stereotactic radiosurgery. Dash(−) means not reported a Type of study: 1) Autopsy – studies where the patients were diagnosed based on autopsy 2) Clinic– studies where diagnosis are made radiological and authors had access to patient history, surgery ...
plasms OR cancer of the colon OR cancer of the rectum OR adenocarcinoma colon OR adenocarcinoma rectum OR adenocarcinoma colorectal OR colonic carcinoma OR rectal carcinoma OR colonic neoplasm OR rectal neoplasm). In EMBASE, the search was conducted by combining subject headings brain metastases/with colorectal adenoma/or colorectal cancer/or ...
27 de mar. de 2023 · Micro-AbstractThe colorectal brain metastases (CBM) are rare, ominous and related to a dismal prognosis. There was still no standard systemic treatment for multiple or unresectable CBM. Due to highly systemic disease control rate by anti-VEGF therapy observed in patients with brain metastases from different cancers, our study was aimed to explore the impact of anti -VEGF therapy on overall ...
25 de jun. de 2018 · Purpose Colorectal cancer (CRC) brain metastases (BM) are an uncommon and late event. We aim to investigate the impact of clinical factors, treatment modalities and RAS/BRAF status on the outcomes of CRC patients with BM. Patients We retrospectively analysed CRC patients who developed BM in our centre between January 1997 and June 2017. Clinical factors, treatment modalities, RAS/BRAF status ...
1 de fev. de 2020 · Brain metastasis (BM) from colorectal cancer is uncommon (0.6-1.36%). This study aims to investigate the patient characteristics, treatment modalities and prognostic factors in this rare population.
